ESR1 and breast carcinoma: Furthermore, the inhibitory effect of XMU-MP-1 on the growth of MCF-7 cells was partially reversed by siRNA-mediated YAP knockdown (KD) (Fig. 2c), suggesting that MST1/2 inhibition blocked ER+ breast cancer cell growth at least in part through YAP.